Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis

Yoshiyasu Esaki, Youxian Li, Daiji Sakata, Chengcan Yao, Eri Segi-Nishida, Toshiyuki Matsuoka, Kazuhiko Fukuda, Shuh Narumiya

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS). Although prostaglandin (PG) concentrations are increased in cerebrospinal fluid of MS patients, the role of PGs in MS is unknown. We examined this issue by subjecting mice deficient in each PG receptor type or subtype to EAE induction and using agonists or antagonists selective for each of the four PGE receptor (EP) subtypes. Among PG receptor-deficient mice, only EP4-/- mice manifested significant suppression of EAE, which was mimicked in wild-type mice and to a greater extent, in EP2 -/- mice by administration of the EP4 antagonist ONO-AE3-208 during the immunization phase. EP4 antagonism during immunization also suppressed the generation of antigen-specific T helper (Th) 1 and Th17 cells in wild-type mice and to a greater extent, in EP2-/- mice. ONO-AE3-208 administration at EAE onset had little effect on disease severity, and its administration throughout the experimental period did not cause significant reduction of the peak of disease, suggesting that, in addition to its facilitative action during the immunization phase, EP4 exerts a preventive action in the elicitation phase. Administration of the EP4 agonist ONO-AE1-329 at EAE onset delayed and suppressed disease progression as well as inhibited the associated increase in permeability of the blood-brain barrier. Thus, PGE2 exerts dual functions in EAE, facilitating Th1 and Th17 cell generation redundantly through EP4 and EP2 during immunization and attenuating invasion of these cells into the brain by protecting the blood-brain barrier through EP4.

Original languageEnglish
Pages (from-to)12233-12238
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number27
DOIs
Publication statusPublished - Jul 6 2010

Fingerprint

Autoimmune Experimental Encephalomyelitis
Dinoprostone
Immunization
Prostaglandin Receptors
Multiple Sclerosis
Th17 Cells
Th1 Cells
Blood-Brain Barrier
Prostaglandin E Receptors
Prostaglandins
Cerebrospinal Fluid
Disease Progression
Permeability
Animal Models
Antigens
Brain

All Science Journal Classification (ASJC) codes

  • General

Cite this

Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. / Esaki, Yoshiyasu; Li, Youxian; Sakata, Daiji; Yao, Chengcan; Segi-Nishida, Eri; Matsuoka, Toshiyuki; Fukuda, Kazuhiko; Narumiya, Shuh.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 27, 06.07.2010, p. 12233-12238.

Research output: Contribution to journalArticle

Esaki, Yoshiyasu ; Li, Youxian ; Sakata, Daiji ; Yao, Chengcan ; Segi-Nishida, Eri ; Matsuoka, Toshiyuki ; Fukuda, Kazuhiko ; Narumiya, Shuh. / Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. In: Proceedings of the National Academy of Sciences of the United States of America. 2010 ; Vol. 107, No. 27. pp. 12233-12238.
@article{7c75476ff68541a8bc04dad9dab1a313,
title = "Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis",
abstract = "Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS). Although prostaglandin (PG) concentrations are increased in cerebrospinal fluid of MS patients, the role of PGs in MS is unknown. We examined this issue by subjecting mice deficient in each PG receptor type or subtype to EAE induction and using agonists or antagonists selective for each of the four PGE receptor (EP) subtypes. Among PG receptor-deficient mice, only EP4-/- mice manifested significant suppression of EAE, which was mimicked in wild-type mice and to a greater extent, in EP2 -/- mice by administration of the EP4 antagonist ONO-AE3-208 during the immunization phase. EP4 antagonism during immunization also suppressed the generation of antigen-specific T helper (Th) 1 and Th17 cells in wild-type mice and to a greater extent, in EP2-/- mice. ONO-AE3-208 administration at EAE onset had little effect on disease severity, and its administration throughout the experimental period did not cause significant reduction of the peak of disease, suggesting that, in addition to its facilitative action during the immunization phase, EP4 exerts a preventive action in the elicitation phase. Administration of the EP4 agonist ONO-AE1-329 at EAE onset delayed and suppressed disease progression as well as inhibited the associated increase in permeability of the blood-brain barrier. Thus, PGE2 exerts dual functions in EAE, facilitating Th1 and Th17 cell generation redundantly through EP4 and EP2 during immunization and attenuating invasion of these cells into the brain by protecting the blood-brain barrier through EP4.",
author = "Yoshiyasu Esaki and Youxian Li and Daiji Sakata and Chengcan Yao and Eri Segi-Nishida and Toshiyuki Matsuoka and Kazuhiko Fukuda and Shuh Narumiya",
year = "2010",
month = "7",
day = "6",
doi = "10.1073/pnas.0915112107",
language = "English",
volume = "107",
pages = "12233--12238",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "27",

}

TY - JOUR

T1 - Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis

AU - Esaki, Yoshiyasu

AU - Li, Youxian

AU - Sakata, Daiji

AU - Yao, Chengcan

AU - Segi-Nishida, Eri

AU - Matsuoka, Toshiyuki

AU - Fukuda, Kazuhiko

AU - Narumiya, Shuh

PY - 2010/7/6

Y1 - 2010/7/6

N2 - Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS). Although prostaglandin (PG) concentrations are increased in cerebrospinal fluid of MS patients, the role of PGs in MS is unknown. We examined this issue by subjecting mice deficient in each PG receptor type or subtype to EAE induction and using agonists or antagonists selective for each of the four PGE receptor (EP) subtypes. Among PG receptor-deficient mice, only EP4-/- mice manifested significant suppression of EAE, which was mimicked in wild-type mice and to a greater extent, in EP2 -/- mice by administration of the EP4 antagonist ONO-AE3-208 during the immunization phase. EP4 antagonism during immunization also suppressed the generation of antigen-specific T helper (Th) 1 and Th17 cells in wild-type mice and to a greater extent, in EP2-/- mice. ONO-AE3-208 administration at EAE onset had little effect on disease severity, and its administration throughout the experimental period did not cause significant reduction of the peak of disease, suggesting that, in addition to its facilitative action during the immunization phase, EP4 exerts a preventive action in the elicitation phase. Administration of the EP4 agonist ONO-AE1-329 at EAE onset delayed and suppressed disease progression as well as inhibited the associated increase in permeability of the blood-brain barrier. Thus, PGE2 exerts dual functions in EAE, facilitating Th1 and Th17 cell generation redundantly through EP4 and EP2 during immunization and attenuating invasion of these cells into the brain by protecting the blood-brain barrier through EP4.

AB - Experimental autoimmune encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS). Although prostaglandin (PG) concentrations are increased in cerebrospinal fluid of MS patients, the role of PGs in MS is unknown. We examined this issue by subjecting mice deficient in each PG receptor type or subtype to EAE induction and using agonists or antagonists selective for each of the four PGE receptor (EP) subtypes. Among PG receptor-deficient mice, only EP4-/- mice manifested significant suppression of EAE, which was mimicked in wild-type mice and to a greater extent, in EP2 -/- mice by administration of the EP4 antagonist ONO-AE3-208 during the immunization phase. EP4 antagonism during immunization also suppressed the generation of antigen-specific T helper (Th) 1 and Th17 cells in wild-type mice and to a greater extent, in EP2-/- mice. ONO-AE3-208 administration at EAE onset had little effect on disease severity, and its administration throughout the experimental period did not cause significant reduction of the peak of disease, suggesting that, in addition to its facilitative action during the immunization phase, EP4 exerts a preventive action in the elicitation phase. Administration of the EP4 agonist ONO-AE1-329 at EAE onset delayed and suppressed disease progression as well as inhibited the associated increase in permeability of the blood-brain barrier. Thus, PGE2 exerts dual functions in EAE, facilitating Th1 and Th17 cell generation redundantly through EP4 and EP2 during immunization and attenuating invasion of these cells into the brain by protecting the blood-brain barrier through EP4.

UR - http://www.scopus.com/inward/record.url?scp=77955464551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955464551&partnerID=8YFLogxK

U2 - 10.1073/pnas.0915112107

DO - 10.1073/pnas.0915112107

M3 - Article

C2 - 20566843

AN - SCOPUS:77955464551

VL - 107

SP - 12233

EP - 12238

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 27

ER -